Healthcare -
Biotechnology - NASDAQ - US
$ 8.52
3.9 %
$ 451 M
Market Cap
-4.1
P/E
STOK - TOTAL LIABILITIES
Total Liabilities STOK - Stoke Therapeutics, Inc.
68.8 M
LAST VALUE
80.59%
2 YEAR CAGR
94.50%
5 YEAR CAGR
0.00%
10 YEAR CAGR